{"id":38060,"date":"2017-03-22T23:55:00","date_gmt":"2017-03-23T03:55:00","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=38060"},"modified":"2017-03-22T23:55:01","modified_gmt":"2017-03-23T03:55:01","slug":"cerulean-pharma-inc-nasdaqceru-and-dare-bioscience-enter-into-stock-purchase-agreement","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/cerulean-pharma-inc-nasdaqceru-and-dare-bioscience-enter-into-stock-purchase-agreement-38060","title":{"rendered":"Cerulean Pharma Inc (NASDAQ:CERU) and Dar\u00e9 Bioscience Enter into Stock Purchase Agreement"},"content":{"rendered":"<p style=\"text-align: justify;\"><strong>Cerulean Pharma Inc <\/strong><strong>(NASDAQ:CERU) <\/strong>and Dar\u00e9 Bioscience, Inc. together with Dar\u00e9 Bioscience\u2019s equity holders have signed a stock purchase agreement that will entitle Dar\u00e9 Bioscience\u2019s equity holders to majority stake in Cerulean. Dar\u00e9 Bioscience, Inc is a privately owned pharmaceutical company engaged in the production of medicinal products for women reproductive health.<\/p>\n<p style=\"text-align: justify;\">The deal as well as the sale of Cerulean asset will enable the pharmaceutical company to concentrate on the development, marketing and commercialization of medicinal products used in women\u2019s reproductive health.<\/p>\n<p style=\"text-align: justify;\">Ovaprene\u00ae, Dar\u00e9 Bioscience\u2019s product candidate is a non-hormonal contraceptive clinical stage candidate that has the potential to address a big need that is unmet. The global contraceptive market is worthy $16 billion. Since FDA approved the use of birth control pill in 1960, subsequent innovations have mainly majored on hormones. Ovaprene, is also Dar\u00e9 Bioscience\u2019s non- hormonal option candidate meant to offer protection over several weeks. At the moment, no product is in the market that can be compared to Dar\u00e9\u2019s products.up on full execution of the deal, the two companies fall under the name of Dar\u00e9 Bioscience with Sabrina Martucci Johnson as the Chief Executive Officer. Sabrina Martucci Johnson is Dar\u00e9 Bioscienc\u2019s Chief Executive Officer. The deal will be have to be approved by Cerulean\u2019s stockholders.<\/p>\n<p style=\"text-align: justify;\">Cerulean has also announced also announced signing two agreements for the sale of its assets. The company intends to use the proceeds from the sale of the assets the merger\u2019s operations. The company sold its clinical product candidates CRLX301, and CRLX101 for $1.5 million to NewLink Genetics Corporation\u2019 subsidiary BlueLink Pharmaceuticals. NewLink Genetics Corporation is a biopharmaceutical firm specializing in the development, marketing and commercialization of immuno-oncology medicinal products candidates to improve the lives of people with cancer.<\/p>\n<p style=\"text-align: justify;\">Additionally, the company has signed an agreement with Novartis under which the later will all Cerulean\u2019s stake in Dynamic Tumor Targeting\u2122 Platform. The deal is worth $6 million. This deal is subject approval by Novartis\u2019 shareholders. In addition to these deals, Cerulean has announced plans to paying off its outstanding debts of its facility with Hercules Capital, Inc.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cerulean Pharma Inc (NASDAQ:CERU) and Dar\u00e9 Bioscience, Inc. together with Dar\u00e9 Bioscience\u2019s equity holders have signed a stock purchase agreement that will entitle Dar\u00e9 Bioscience\u2019s [&hellip;]<\/p>\n","protected":false},"author":15,"featured_media":38102,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[12406,12405,12407],"stock_ticker":[],"class_list":["post-38060","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-cerulean-pharma-inc","tag-cerulean-pharma-inc-nasdaqceru","tag-nasdaqceru","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cerulean Pharma Inc (NASDAQ:CERU) and Dar\u00e9 Bioscience Enter into Stock Purchase Agreement - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/cerulean-pharma-inc-nasdaqceru-and-dare-bioscience-enter-into-stock-purchase-agreement-38060\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cerulean Pharma Inc (NASDAQ:CERU) and Dar\u00e9 Bioscience Enter into Stock Purchase Agreement - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Cerulean Pharma Inc (NASDAQ:CERU) and Dar\u00e9 Bioscience, Inc. together with Dar\u00e9 Bioscience\u2019s equity holders have signed a stock purchase agreement that will entitle Dar\u00e9 Bioscience\u2019s [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/cerulean-pharma-inc-nasdaqceru-and-dare-bioscience-enter-into-stock-purchase-agreement-38060\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-03-23T03:55:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2017-03-23T03:55:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/03\/38101-images__4_.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"308\" \/>\n\t<meta property=\"og:image:height\" content=\"164\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Benjamin Roussey\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benjamin Roussey\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cerulean-pharma-inc-nasdaqceru-and-dare-bioscience-enter-into-stock-purchase-agreement-38060#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cerulean-pharma-inc-nasdaqceru-and-dare-bioscience-enter-into-stock-purchase-agreement-38060\"},\"author\":{\"name\":\"Benjamin Roussey\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\"},\"headline\":\"Cerulean Pharma Inc (NASDAQ:CERU) and Dar\u00e9 Bioscience Enter into Stock Purchase Agreement\",\"datePublished\":\"2017-03-23T03:55:00+00:00\",\"dateModified\":\"2017-03-23T03:55:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cerulean-pharma-inc-nasdaqceru-and-dare-bioscience-enter-into-stock-purchase-agreement-38060\"},\"wordCount\":367,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cerulean-pharma-inc-nasdaqceru-and-dare-bioscience-enter-into-stock-purchase-agreement-38060#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/03\/38101-images__4_.jpeg\",\"keywords\":[\"Cerulean Pharma Inc\",\"Cerulean Pharma Inc (NASDAQ:CERU)\",\"NASDAQ:CERU\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/cerulean-pharma-inc-nasdaqceru-and-dare-bioscience-enter-into-stock-purchase-agreement-38060#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cerulean-pharma-inc-nasdaqceru-and-dare-bioscience-enter-into-stock-purchase-agreement-38060\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cerulean-pharma-inc-nasdaqceru-and-dare-bioscience-enter-into-stock-purchase-agreement-38060\",\"name\":\"Cerulean Pharma Inc (NASDAQ:CERU) and Dar\u00e9 Bioscience Enter into Stock Purchase Agreement - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cerulean-pharma-inc-nasdaqceru-and-dare-bioscience-enter-into-stock-purchase-agreement-38060#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cerulean-pharma-inc-nasdaqceru-and-dare-bioscience-enter-into-stock-purchase-agreement-38060#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/03\/38101-images__4_.jpeg\",\"datePublished\":\"2017-03-23T03:55:00+00:00\",\"dateModified\":\"2017-03-23T03:55:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cerulean-pharma-inc-nasdaqceru-and-dare-bioscience-enter-into-stock-purchase-agreement-38060#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/cerulean-pharma-inc-nasdaqceru-and-dare-bioscience-enter-into-stock-purchase-agreement-38060\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cerulean-pharma-inc-nasdaqceru-and-dare-bioscience-enter-into-stock-purchase-agreement-38060#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/03\/38101-images__4_.jpeg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/03\/38101-images__4_.jpeg\",\"width\":308,\"height\":164},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cerulean-pharma-inc-nasdaqceru-and-dare-bioscience-enter-into-stock-purchase-agreement-38060#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cerulean Pharma Inc (NASDAQ:CERU) and Dar\u00e9 Bioscience Enter into Stock Purchase Agreement\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\",\"name\":\"Benjamin Roussey\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"caption\":\"Benjamin Roussey\"},\"description\":\"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cerulean Pharma Inc (NASDAQ:CERU) and Dar\u00e9 Bioscience Enter into Stock Purchase Agreement - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/cerulean-pharma-inc-nasdaqceru-and-dare-bioscience-enter-into-stock-purchase-agreement-38060","og_locale":"en_US","og_type":"article","og_title":"Cerulean Pharma Inc (NASDAQ:CERU) and Dar\u00e9 Bioscience Enter into Stock Purchase Agreement - Wall Street PR","og_description":"Cerulean Pharma Inc (NASDAQ:CERU) and Dar\u00e9 Bioscience, Inc. together with Dar\u00e9 Bioscience\u2019s equity holders have signed a stock purchase agreement that will entitle Dar\u00e9 Bioscience\u2019s [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/cerulean-pharma-inc-nasdaqceru-and-dare-bioscience-enter-into-stock-purchase-agreement-38060","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2017-03-23T03:55:00+00:00","article_modified_time":"2017-03-23T03:55:01+00:00","og_image":[{"width":308,"height":164,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/03\/38101-images__4_.jpeg","type":"image\/jpeg"}],"author":"Benjamin Roussey","twitter_misc":{"Written by":"Benjamin Roussey","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cerulean-pharma-inc-nasdaqceru-and-dare-bioscience-enter-into-stock-purchase-agreement-38060#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cerulean-pharma-inc-nasdaqceru-and-dare-bioscience-enter-into-stock-purchase-agreement-38060"},"author":{"name":"Benjamin Roussey","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d"},"headline":"Cerulean Pharma Inc (NASDAQ:CERU) and Dar\u00e9 Bioscience Enter into Stock Purchase Agreement","datePublished":"2017-03-23T03:55:00+00:00","dateModified":"2017-03-23T03:55:01+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cerulean-pharma-inc-nasdaqceru-and-dare-bioscience-enter-into-stock-purchase-agreement-38060"},"wordCount":367,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cerulean-pharma-inc-nasdaqceru-and-dare-bioscience-enter-into-stock-purchase-agreement-38060#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/03\/38101-images__4_.jpeg","keywords":["Cerulean Pharma Inc","Cerulean Pharma Inc (NASDAQ:CERU)","NASDAQ:CERU"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/cerulean-pharma-inc-nasdaqceru-and-dare-bioscience-enter-into-stock-purchase-agreement-38060#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cerulean-pharma-inc-nasdaqceru-and-dare-bioscience-enter-into-stock-purchase-agreement-38060","url":"https:\/\/cablemanpro.com\/wallstreetpr\/cerulean-pharma-inc-nasdaqceru-and-dare-bioscience-enter-into-stock-purchase-agreement-38060","name":"Cerulean Pharma Inc (NASDAQ:CERU) and Dar\u00e9 Bioscience Enter into Stock Purchase Agreement - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cerulean-pharma-inc-nasdaqceru-and-dare-bioscience-enter-into-stock-purchase-agreement-38060#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cerulean-pharma-inc-nasdaqceru-and-dare-bioscience-enter-into-stock-purchase-agreement-38060#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/03\/38101-images__4_.jpeg","datePublished":"2017-03-23T03:55:00+00:00","dateModified":"2017-03-23T03:55:01+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cerulean-pharma-inc-nasdaqceru-and-dare-bioscience-enter-into-stock-purchase-agreement-38060#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/cerulean-pharma-inc-nasdaqceru-and-dare-bioscience-enter-into-stock-purchase-agreement-38060"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cerulean-pharma-inc-nasdaqceru-and-dare-bioscience-enter-into-stock-purchase-agreement-38060#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/03\/38101-images__4_.jpeg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/03\/38101-images__4_.jpeg","width":308,"height":164},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cerulean-pharma-inc-nasdaqceru-and-dare-bioscience-enter-into-stock-purchase-agreement-38060#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Cerulean Pharma Inc (NASDAQ:CERU) and Dar\u00e9 Bioscience Enter into Stock Purchase Agreement"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d","name":"Benjamin Roussey","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","caption":"Benjamin Roussey"},"description":"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/38060","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=38060"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/38060\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/38102"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=38060"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=38060"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=38060"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=38060"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}